Clinical trial
Evaluate the Safety of Colchicine for Treatment and Prevention of Radiation-Induced Dermatitis
NCT05335148 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluate the Safety of Colchicine for Treatment and Prevention of Radiation-Induced Dermatitis
- Lead sponsor
- Rutgers, The State University of New Jersey
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- May 10, 2022
- Completion date
- June 1, 2027
- Enrollment
- 30 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
radiation therapy